Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03311971
Other study ID # 0428-17-RMC
Secondary ID
Status Active, not recruiting
Phase Phase 4
First received
Last updated
Start date November 30, 2017
Est. completion date January 1, 2019

Study information

Verified date August 2018
Source Rabin Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The trial aims to evaulate the possiblity that use of virtual reality spectacles will affect post operative pain in total knee arthroplasty patients. The trial is a single center open label design. Patients will be randomized into two arm study comparing the effect of the use of virtual reality spectacles on pain levels and analgesic consumption in the perioperative period. The controls shall receive standard post operative care. The endpoints are VAS levels and analgesic use.


Description:

Evaluation Procedure This is a single center, interventional, randomized, unblinded two arm study assessing pain and analgesic use in post knee arthroplasty patients. The randomization ratio is 2:1 intervention to control. Both groups will receive routine post operative care. The intervention group will be treated with virtual reality spectacles. The control group will receive routine post operative care. Pain levels will be assessed using VAS and analgesic use.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 50
Est. completion date January 1, 2019
Est. primary completion date September 30, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing total knee arthroplasty gender indifferent, aged over 18 years old

- Patient with ability to see in three dimensions

Exclusion Criteria:

- Inability to comply with the study protocol

- Single eye vision

- Blindness

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Virtual reality glasses
Patients will be treated with virtual glasses
No VR glasses
Patients will not use VR glasses

Locations

Country Name City State
Israel Hasharon Hospital Peta? Tiqwa

Sponsors (1)

Lead Sponsor Collaborator
Rabin Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary VAS pain response questionnaires One week
Secondary Analgesic use amount of analgesic medication consumed one week